PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 3, 2006Cancer549 citationsOpen Access

Prognosis of medullary thyroid carcinoma

View Full Paper
SRSanziana A. RomanRLRong LinJSJulie Ann Sosa

Key Points

Key points are not available for this paper at this time.

Abstract

Stage of disease and age at diagnosis were found to be the strongest predictors of survival for patients with MTC. To the authors' knowledge there has been no change in stage at diagnosis or a significant improvement in survival noted over the last 30 years. Many patients underwent surgery that was deemed less than optimal for stage of disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Roman et al. (2006) studied this question.

synapsesocial.com/papers/69da2667a6045d71bfa3c401https://doi.org/10.1002/cncr.22244
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Importance of Surgeon Experience for Clinical and Economic Outcomes From Thyroidectomy1998 · 1,117 citations
  2. 2Prognostic factors for thyroid carcinoma1997 · 807 citations
  3. 3The management of thyroid cancer in adults: a review of new guidelines2002 · 29 citations
  4. 4Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.1990 · 38 citations
  5. 5Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine1995 · 169 citations